Millions of dollars in a new state budget proposal could allow for the return of GLP-1 coverage for some state employees.

During the time period 2020 to 2023, approximately 1 in 5 youth and 1 in 3 adults with type 1 diabetes and severe obesity ...

Data from Phase 2 Trial VGX-001-012 of Mizagliflozin in Post Bariatric Hypoglycemia will be Presented RALEIGH, NC / ACCESS Newswire / April 15, 2025 /Vogenx, Inc., a clinical-stage developer of novel ...

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

Stay up-to-date with the Axis Bank Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

TORONTO - A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health ...

FTSE 100 Index 8,249.12 114.78 1.41% ...

Fortinet Inc. $99.20 2.35 2.43% ...